Prof. Liu Zhibo's team from Peking University (PKU)'s College of Chemistry and Molecular Engineering, along with collaborators, recently published a paper titled "Covalent targeted radioligands potentiate radionuclide therapy" ...
Jun 4, 2024
0
0
Lung cancer can advance quickly. Once a person starts treatment, it is vital to know whether that treatment is working or if the patient should be switched to a different treatment. New advanced imaging technology at UC Davis ...
Jun 10, 2024
0
0
Brain cancer is difficult to treat when it starts growing, and a prevalent type, known as a glioma, has a poor five-year survival rate. In a new study published in Proceedings of the National Academy of Sciences, Mayo Clinic ...
May 30, 2024
0
71
In the relentless fight against cancer, a new technology promises to shed light on how we track and understand the spread of this disease within the body. A research team from Northeastern University and Dartmouth College ...
Jun 7, 2024
0
1
Adding CD28 costimulation to cord blood-derived chimeric antigen receptor (CAR) natural killer (NK) cells targeting CD70+ cancers significantly enhanced antitumor efficacy and long-term cytotoxicity of the CAR NK cells, according ...
Jun 20, 2024
0
1
In an editorial, researchers Gregory L. Guzik and Ankit Mangla from University Hospitals Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Western Reserve University School of Medicine, and Case Comprehensive ...
Jun 21, 2024
0
0
Cancer remains one of the most formidable public health challenges, causing significant mortality globally. In 2022 alone, there were approximately 19.3 million new cancer diagnoses and 10 million cancer-related deaths worldwide. ...
May 31, 2024
0
0
Blocking a protein known as CDK7 could prevent heart damage associated with a commonly used cancer chemotherapy medication, according to a study led by scientists at Washington State University. Importantly, the researchers ...
Jun 3, 2024
0
0
Combination of alpha- and beta-radionuclide therapy is feasible, tolerable, and effective for colorectal cancer, according to preclinical research presented at the 2024 Society of Nuclear Medicine and Molecular Imaging Annual ...
Jun 12, 2024
0
0
Cancer poses significant challenges due to the development of resistance and the likelihood of relapse. Resistance may arise from permanent genetic changes in cancer cells or non-genetic alterations in cancer cell behavior ...
May 28, 2024
0
0
